Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel series of glucokinase activators presented by Takeda

Jan. 14, 2010

FDA advisory committee recommends approval of Actelion's sNDA for Zavesca

Jan. 14, 2010

Pharming provides business update

Jan. 14, 2010

Savient presents update on BLA resubmission for Krystexxa for chronic gout

Jan. 13, 2010

Antares and Population Council report phase II trial results for transdermal contraceptive gel

Jan. 13, 2010

Delay in FDA review of MannKind's NDA for Afrezza

Jan. 12, 2010

Tekmira Pharmaceuticals completes phase I clinical trial of ApoB SNALP

Jan. 11, 2010

Tolerx completes enrollment in phase III DEFEND-1 study in type 1 diabetes

Jan. 11, 2010

3SBio applies for registrational trial of Feraheme in China

Jan. 11, 2010

Leptin beneficial in patients with various forms of lipodystrophy

Jan. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...